170 related articles for article (PubMed ID: 26912376)
1. Safety and risk factors for difficult endoscopist-directed ERCP sedation in daily practice: a hospital-based case-control study.
Pérez-Cuadrado Robles E; González Ramírez A; Lancho Seco Á; Martí Marqués E; Dacal Rivas A; Castro Ortiz E; González Soler R; Álvarez Suárez B; Tardáguila García D; López Baz A; Fernández López A; López Roses L
Rev Esp Enferm Dig; 2016 May; 108(5):240-5. PubMed ID: 26912376
[TBL] [Abstract][Full Text] [Related]
2. The safety of deep sedation with propofol controlled by the endoscopist in endoscopic retrograde cholangiopancreatography (ERCP): a prospective study in a tertiary hospital.
Luzón Solanas L; Ollero Domenche L; Sierra Moros EM; Val Pérez J; Soria San Teodoro MT; Giménez Júlvez T; Uribarrena Amezaga R
Rev Esp Enferm Dig; 2018 Apr; 110(4):217-222. PubMed ID: 29421914
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation of elderly patients undergoing ERCP.
Zhang Y; Zhang N; Hu J; Liu C; Li G
BMC Gastroenterol; 2024 Apr; 24(1):124. PubMed ID: 38566038
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of midazolam- versus propofol-based sedations by non-anesthesiologists during therapeutic endoscopic retrograde cholangiopancreatography in patients aged over 80 years.
Han SJ; Lee TH; Park SH; Cho YS; Lee YN; Jung Y; Choi HJ; Chung IK; Cha SW; Moon JH; Cho YD; Kim SJ
Dig Endosc; 2017 May; 29(3):369-376. PubMed ID: 28181706
[TBL] [Abstract][Full Text] [Related]
5. Bispectral index monitoring as an adjunct to nurse-administered combined sedation during endoscopic retrograde cholangiopancreatography.
Jang SY; Park HG; Jung MK; Cho CM; Park SY; Jeon SW; Tak WY; Kweon YO; Kim SK; Jeon YH
World J Gastroenterol; 2012 Nov; 18(43):6284-9. PubMed ID: 23180950
[TBL] [Abstract][Full Text] [Related]
6. Sedation with propofol for routine ERCP in high-risk octogenarians: a randomized, controlled study.
Riphaus A; Stergiou N; Wehrmann T
Am J Gastroenterol; 2005 Sep; 100(9):1957-63. PubMed ID: 16128939
[TBL] [Abstract][Full Text] [Related]
7. Deep sedation for endoscopic cholangiopancreatography with or without pre or intraprocedural opioids: A double-blind randomised controlled trial.
Fassoulaki A; Iatrelli I; Vezakis A; Polydorou A
Eur J Anaesthesiol; 2015 Sep; 32(9):602-8. PubMed ID: 25405276
[TBL] [Abstract][Full Text] [Related]
8. Bispectral index monitoring of midazolam and propofol sedation during endoscopic retrograde cholangiopancreatography: a randomized clinical trial (the EndoBIS study).
von Delius S; Salletmaier H; Meining A; Wagenpfeil S; Saur D; Bajbouj M; Schneider G; Schmid RM; Huber W
Endoscopy; 2012 Mar; 44(3):258-64. PubMed ID: 22261747
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial on use of propofol alone versus propofol with midazolam, ketamine, and pentazocine "sedato-analgesic cocktail" for sedation during ERCP.
Ong WC; Santosh D; Lakhtakia S; Reddy DN
Endoscopy; 2007 Sep; 39(9):807-12. PubMed ID: 17703390
[TBL] [Abstract][Full Text] [Related]
10. Capnographic monitoring of propofol-based sedation during colonoscopy.
Friedrich-Rust M; Welte M; Welte C; Albert J; Meckbach Y; Herrmann E; Kannengiesser M; Trojan J; Filmann N; Schroeter H; Zeuzem S; Bojunga J
Endoscopy; 2014 Mar; 46(3):236-44. PubMed ID: 24338242
[TBL] [Abstract][Full Text] [Related]
11. Capnographic monitoring of midazolam and propofol sedation during ERCP: a randomized controlled study (EndoBreath Study).
Klare P; Reiter J; Meining A; Wagenpfeil S; Kronshage T; Geist C; Heringlake S; Schlag C; Bajbouj M; Schneider G; Schmid RM; Wehrmann T; von Delius S; Riphaus A
Endoscopy; 2016 Jan; 48(1):42-50. PubMed ID: 26415090
[TBL] [Abstract][Full Text] [Related]
12. Deep sedation for endoscopic retrograde cholangiopancreatography: intravenous propofol alone versus intravenous propofol with oral midazolam premedication.
Paspatis GA; Manolaraki MM; Vardas E; Theodoropoulou A; Chlouverakis G
Endoscopy; 2008 Apr; 40(4):308-13. PubMed ID: 18058653
[TBL] [Abstract][Full Text] [Related]
13. Propofol versus midazolam for procedural sedation in the emergency department: A study on efficacy and safety.
Lameijer H; Sikkema YT; Pol A; Bosch MGE; Beije F; Feenstra R; Bens BWJ; Ter Avest E
Am J Emerg Med; 2017 May; 35(5):692-696. PubMed ID: 28073611
[TBL] [Abstract][Full Text] [Related]
14. Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam.
Jung M; Hofmann C; Kiesslich R; Brackertz A
Endoscopy; 2000 Mar; 32(3):233-8. PubMed ID: 10718389
[TBL] [Abstract][Full Text] [Related]
15. Propofol versus midazolam for conscious sedation guided by processed EEG during endoscopic retrograde cholangiopancreatography: a prospective, randomized, double-blind study.
Krugliak P; Ziff B; Rusabrov Y; Rosenthal A; Fich A; Gurman GM
Endoscopy; 2000 Sep; 32(9):677-82. PubMed ID: 10989990
[TBL] [Abstract][Full Text] [Related]
16. Safety of non-anaesthesiologist-administered propofol sedation in ERCP.
Khan HA; Umar M; Tul-Bushra H; Nisar G; Bilal M; Umar S
Arab J Gastroenterol; 2014 Mar; 15(1):32-5. PubMed ID: 24630512
[TBL] [Abstract][Full Text] [Related]
17. Nurse-administered propofol sedation for endoscopy: a risk analysis during an implementation phase.
Jensen JT; Vilmann P; Horsted T; Hornslet P; Bodtger U; Banning A; Hammering A
Endoscopy; 2011 Aug; 43(8):716-22. PubMed ID: 21811940
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of etomidate-based sedation compared with propofol-based sedation during ERCP in low-risk patients: a double-blind, randomized, noninferiority trial.
Park CH; Park SW; Hyun B; Lee J; Kae SH; Jang HJ; Koh DH; Choi MH
Gastrointest Endosc; 2018 Jan; 87(1):174-184. PubMed ID: 28610897
[TBL] [Abstract][Full Text] [Related]
19. Age correlates with hypotension during propofol-based anesthesia for endoscopic retrograde cholangiopancreatography.
Khoi CS; Wong JJ; Wang HC; Lu CW; Lin TY
Acta Anaesthesiol Taiwan; 2015 Dec; 53(4):131-4. PubMed ID: 26627000
[TBL] [Abstract][Full Text] [Related]
20. Endoscopist administered sedation during ERCP: impact of chronic narcotic/benzodiazepine use and predictive risk of reversal agent utilization.
Papachristou GI; Gleeson FC; Papachristou DJ; Petersen BT; Baron TH
Am J Gastroenterol; 2007 Apr; 102(4):738-43. PubMed ID: 17324132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
